Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. MRNA
7. CSX
8. SPCX
9. WDC
10. QGEN

Go back to Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates

Fortress Biotech (FBIO) PT Raised to $13 at Roth/MKM

August 14, 2024 5:06 AM EDT

Roth/MKM analyst Jason Whittes raised the price target on Fortress Biotech (NASDAQ: FBIO) to $13.00 (from $10.00) while maintaining a Buy rating.

The analyst comments "FBIO reported 2Q24 revenues down 14.4% to $14.9 million vs. consensus of $14.8 million and our estimate of $14.0 million. EPS was ($0.73) vs.... More